Dara Wright

CIK 1796980 · View on SEC EDGAR ↗

Insider

First SEC filing: Dec. 17, 2019 · Latest: Dec. 17, 2019

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 36 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

36 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 12, 2023 BIO S 1,200 $299.16 $358,992 1,499 Direct -44.46% Disposed 19.0% (price as of 2026-08-18)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Dec. 16, 2023 BIO Restricted Stock Units Bio-Rad A Common Stock (502) — — 502 Disposed
Sept. 2, 2023 BIO Restricted Stock Units Bio-Rad A Common Stock (433) — — 433 Disposed
Sept. 1, 2023 BIO Restricted Stock Units Bio-Rad A Common Stock (405) — — 405 Disposed
Sept. 1, 2023 BIO Restricted Stock Units Bio-Rad A Common Stock (520) — — 520 Disposed
Sept. 1, 2023 BIO Restricted Stock Units Bio-Rad A Common Stock (3,005) — — 3,005 Acquired
Dec. 16, 2022 BIO Restricted Stock Units Bio-Rad A Common Stock (502) — — 502 Disposed
Sept. 2, 2022 BIO Restricted Stock Units Bio-Rad A Common Stock (433) — — 433 Disposed
Sept. 1, 2022 BIO Restricted Stock Units Bio-Rad A Common Stock (405) — — 405 Disposed
Sept. 1, 2022 BIO Restricted Stock Units Bio-Rad A Common Stock (2,082) — — 2,082 Acquired
Dec. 16, 2021 BIO Restricted Stock Units Bio-Rad A Common Stock (502) — — 502 Disposed
Sept. 2, 2021 BIO Restricted Stock Units Bio-Rad A Common Stock (433) — — 433 Disposed
Sept. 1, 2021 BIO Non-Qualified Stock Option (right to buy) Bio-Rad A Common Stock (1,621) $814.95 Sept. 1, 2031 1,621 Acquired
Sept. 1, 2021 BIO Restricted Stock Units Bio-Rad A Common Stock (1,621) — — 1,621 Acquired
Dec. 16, 2020 BIO Restricted Stock Units Bio-Rad A Common Stock (502) — — 502 Disposed
Dec. 16, 2019 BIO Restricted Stock Units Bio-Rad A Common Stock (2,511) — — 2,511 Acquired
Dec. 16, 2019 BIO Non-Qualified Stock Option (right to buy) Bio-Rad A Common Stock (2,511) $366.89 Dec. 16, 2029 2,511 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Dec. 17, 2019 BIO No securities beneficially owned 0 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BIO

President, Clinical Diagnostics Group
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2023 $562,390 — — — — — $17,760 $2,133,126

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.